This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Self-Management » Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Uncontrolled Type 2 Diabetes Patients More Likely to Start Insulin When Inhaled Insulin Is an Option

Posted: Wednesday, April 25, 2007

The availability of inhaled insulin may increase the number of patients with uncontrolled type 2 diabetes who are willing to start or intensify insulin therapy.

Traditional Insulin Compares Well Against Analogs

Posted: Wednesday, April 25, 2007

Newer long-acting insulin analogs are only marginally better at preventing nighttime hypoglycemia than traditional NPH insulin, found investigators here in a systematic review.

Insulin Glargine: Eight Years Later

Posted: Saturday, April 07, 2007

Insulin Glargine has become the most widely used insulin in the USA owing to its long duration of action without a pronounced peak. This introduction of a new form of insulin has made a dramatic effect on the ability of people to control their blood sugars. But is it being used properly? Should it be given once or twice a day?

Risks OF Tight Glucose Control In ICU Outweigh Benefits

Posted: Thursday, March 15, 2007

Intensive care physicians need to "think hard and long" about aiming for tight glycemic control. "We need to be very conservative about starting insulin regimens the minute someone comes into the ICU."

Insulin Glargine Benefits Uncontrolled Type 2’s on Oral Meds Without Weight Gain

Posted: Thursday, January 18, 2007

Over 2000 type 2 patients lower their A1c 1.7 pts when insulin gargine is added to their oral therapy without weight gain.

Exubera Slow to Catch On

Posted: Thursday, December 07, 2006

Jury is still out on Exubera. Diabetics are holding their breath, and that may not be good news for the Pfizer, the world's biggest drugmaker. It's been nearly a year since the FDA approved Exubera, the first inhalable form of insulin for diabetics. Some analysts hail the device as a potential blockbuster, but Exubera doesn't appear to have caught on.

More Treatment Options for Diabetes Means Few Excuses for High Blood Sugar

Posted: Thursday, November 16, 2006

A generation ago, there was just one kind of pill that could help people with diabetes keep their blood sugar levels down. But today, so many new options are available that it's almost dizzying. Advertisements for the new medicines seem to be everywhere, and more new medicines are on the way.

Patients Miscode Monitors 16% of the Time Causing Faulty Readings

Posted: Thursday, November 16, 2006

When persons with diabetes use miscoded blood glucose meters to determine how much insulin to take, significant errors in insulin dose can result that may potentially lead to short- and long-term health complications.

Insulin Pump Therapy for Adolescents is More Effective with Proper Training

Posted: Thursday, November 09, 2006

Researchers have shown that when adolescents are checking their blood sugars 4 to 5 time a day prior to going on the pump, that more than 80% of adolescents will continue with pump therapy and improve their outcomes.

Switch To Insulin Pen Improves Clinical Outcomes And Reduces Medical Costs

Posted: Thursday, November 02, 2006

Total all-cause annual treatment costs reduced by $1590 per patient.